Video file
Available Dates
November 10-11, 2026 | Boston, MA
Abstract Submissions
Abstract Submissions
Abstracts
Share your research. Shape the future of oncology clinical pathways.
At the Clinical Pathways Congress, we bring together clinicians, operational leaders, payers and innovators to advance evidence, execution, and value in oncology care.
Now more than ever, pathways matter—but only if they are powered by data, implementation, and meaningful outcomes.
That’s why we invite your original research, real-world analyses, quality improvement initiatives, and innovative models in clinical pathways for presentation at the 2026 meeting.
Why submit an abstract?
- Gain exposure to 400+ oncology and value-based care professionals at the Congress.
- Be featured in the official meeting materials and published in the peer-reviewed companion journal and official media partner, Journal of Clinical Pathways.
- Compete for the Innovation Award (see details below) and stand out in the field of clinical pathways research.
- Network with collaborators, decision-makers, and specialists who can help bring your work to broader impact.
Innovation Award—Recognizing Transformational Ideas
We're excited to highlight an Innovation Award for the top submission in clinical pathways. This is your chance not just to present, but to be recognized for pioneering work that challenges the status quo, accelerates implementation or reimagines how care is delivered.
Award criteria:
- Originality: novel methodology, new data or a unique pathway-model innovation
- Impact: demonstrable or projected effect on care delivery, cost, quality, or patient outcomes
- Scalability: feasible for broader adaptation, not just a single-site pilot
- Presentation quality: clarity of aims, methods, results and conclusion; coherence and relevance to pathways and value-based oncology
The Innovation Award winner will receive:
- A featured presentation slot at the Congress
- Recognition during the opening plenary
- Special mentions in the Journal of Clinical Pathways and Congress promotional materials
- A commemorative plaque and award brand package for personal promotion
At the Clinical Pathways Congress, we bring together clinicians, operational leaders, payers and innovators to advance evidence, execution, and value in oncology care.
Now more than ever, pathways matter—but only if they are powered by data, implementation, and meaningful outcomes.
That’s why we invite your original research, real-world analyses, quality improvement initiatives, and innovative models in clinical pathways for presentation at the 2026 meeting.
Why submit an abstract?
- Gain exposure to 400+ oncology and value-based care professionals at the Congress.
- Be featured in the official meeting materials and published in the peer-reviewed companion journal and official media partner, Journal of Clinical Pathways.
- Compete for the Innovation Award (see details below) and stand out in the field of clinical pathways research.
- Network with collaborators, decision-makers, and specialists who can help bring your work to broader impact.
Innovation Award—Recognizing Transformational Ideas
We're excited to highlight an Innovation Award for the top submission in clinical pathways. This is your chance not just to present, but to be recognized for pioneering work that challenges the status quo, accelerates implementation or reimagines how care is delivered.
Award criteria:
- Originality: novel methodology, new data or a unique pathway-model innovation
- Impact: demonstrable or projected effect on care delivery, cost, quality, or patient outcomes
- Scalability: feasible for broader adaptation, not just a single-site pilot
- Presentation quality: clarity of aims, methods, results and conclusion; coherence and relevance to pathways and value-based oncology
The Innovation Award winner will receive:
- A featured presentation slot at the Congress
- Recognition during the opening plenary
- Special mentions in the Journal of Clinical Pathways and Congress promotional materials
- A commemorative plaque and award brand package for personal promotion
What We're Looking For
We welcome submissions addressing any phase of oncology clinical pathways, from prevention to survivorship, and the business, infrastructure and ethics of care. Topics may include—but are not limited to:
- Prevention & Diagnosis: Early detection, staging, and risk stratification for cancer prevention
- Treatment: Personalized treatment pathways, multimodal therapy optimization, care coordination
- Prehabilitation: Nutritional/functional optimization, supportive-care & navigation
- Outcome Measurements: Patient-reported outcomes, resource utilization, benchmarking
- Consistency & Ethics: Guideline adherence, documentation, safety, privacy
- After Treatment: Survivorship and after-treatment care, monitoring, rehabilitation, wellness support
- Palliative & End-of-Life Care: Pathway design, interprofessional integration, navigation
- Infrastructure & Innovation: Data architecture, AI, interoperability, pathway automation
- Business: Alternative payment models, HEOR, cost modeling, value-metric alignment
These align with the structures we use at the Journal of Clinical Pathways and the Congress programming.
We welcome submissions addressing any phase of oncology clinical pathways, from prevention to survivorship, and the business, infrastructure and ethics of care. Topics may include—but are not limited to:
- Prevention & Diagnosis: Early detection, staging, and risk stratification for cancer prevention
- Treatment: Personalized treatment pathways, multimodal therapy optimization, care coordination
- Prehabilitation: Nutritional/functional optimization, supportive-care & navigation
- Outcome Measurements: Patient-reported outcomes, resource utilization, benchmarking
- Consistency & Ethics: Guideline adherence, documentation, safety, privacy
- After Treatment: Survivorship and after-treatment care, monitoring, rehabilitation, wellness support
- Palliative & End-of-Life Care: Pathway design, interprofessional integration, navigation
- Infrastructure & Innovation: Data architecture, AI, interoperability, pathway automation
- Business: Alternative payment models, HEOR, cost modeling, value-metric alignment
These align with the structures we use at the Journal of Clinical Pathways and the Congress programming.
Submission Guidelines
- Deadline: Abstracts open June 1, 2026. Abstracts close October 15, 2026.
- Word/character limit: 2,500 words. Title should be concise and in title case; the body should clearly state aim, methods, results, and conclusion. Avoid placeholders such as “results pending.”
- Originality: Submitted abstracts must not have been published or presented prior to November 10, 2026, unless they contain substantially new data.
- Authors & affiliations: Include authors, contact information (including city, state/province, country). Use standard abbreviations.
- Disclosure: All authors must disclose conflicts of interest or sponsorship before submission.
- Presentation requirement: If the abstract is accepted, the presenting author must register for the Congress and create a companion digital abstract poster in PowerPoint format (1 slide).
- Selection process: All abstracts will be reviewed by a blinded committee for relevance, scientific/educational content, innovation, and pathway impact.
- Award consideration: All accepted abstracts will automatically be considered for the Innovation Award. Judges may invite select abstracts for short oral "Award Finalist" presentations.
- Notification & next steps: Acceptance notifications will be emailed on a rolling basis. Presenters must confirm registration and attendance by October 23, 2026.
- Withdrawal policy: Abstracts must be withdrawn by October 23, 2026, if the authors cannot present; after that, changes cannot be made.
- Deadline: Abstracts open June 1, 2026. Abstracts close October 15, 2026.
- Word/character limit: 2,500 words. Title should be concise and in title case; the body should clearly state aim, methods, results, and conclusion. Avoid placeholders such as “results pending.”
- Originality: Submitted abstracts must not have been published or presented prior to November 10, 2026, unless they contain substantially new data.
- Authors & affiliations: Include authors, contact information (including city, state/province, country). Use standard abbreviations.
- Disclosure: All authors must disclose conflicts of interest or sponsorship before submission.
- Presentation requirement: If the abstract is accepted, the presenting author must register for the Congress and create a companion digital abstract poster in PowerPoint format (1 slide).
- Selection process: All abstracts will be reviewed by a blinded committee for relevance, scientific/educational content, innovation, and pathway impact.
- Award consideration: All accepted abstracts will automatically be considered for the Innovation Award. Judges may invite select abstracts for short oral "Award Finalist" presentations.
- Notification & next steps: Acceptance notifications will be emailed on a rolling basis. Presenters must confirm registration and attendance by October 23, 2026.
- Withdrawal policy: Abstracts must be withdrawn by October 23, 2026, if the authors cannot present; after that, changes cannot be made.
More about Abstracts
FAQs
FAQs
- Can I submit more than one abstract?
Yes—multiple submissions are permitted as long as each meets the criteria and is authored independently.
- If my work has been presented at another meeting, can I still submit?
Yes—provided the submission includes substantially new data, analysis, or follow-up beyond what was presented previously.
- Are industry-sponsored abstracts allowed?
Yes. Industry-sponsored research is welcome, but it must meet all disclosure requirements and contribute to the pathway, value, or care-delivery ecosystem.
- What formats are accepted?
We accept original research, quality improvement initiatives, real-world evidence, case series with a pathway focus, and implementation science. Each must clearly align with oncology clinical pathways or value-based oncology care.
- How is the Innovation Award winner chosen?
The Award Committee will evaluate all accepted abstracts, invite finalists to present in a dedicated session, and announce the winner at the Congress opening. Criteria: novelty, measurable impact, scalability, clarity of presentation.
-
Back to top